14 days of Premium, free.
Every scanner with live hit rates + the Market Pulse risk flag that tells you when to get defensive. No card required.
Start trial →
Tradestie Institutional Equity Comparison Engine · Market Close Nov 16, 2026
SPRC vs FEMY: Which Stock Is the Better Buy Now?
Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.
As of Nov 16, 2026, Femasys Inc. (FEMY) is the stronger overall head-to-head candidate over SciSparc Ltd. (SPRC) in the Tradestie Institutional Equity Comparison Engine, winning 5–2 core matrix metrics and 2–2 across our 6-pillar institutional scorecard (led by Growth & Scale, Balance Sheet & Cash Flow). SPRC carries a Unified Composite Score of 49.8/100 (HOLD) at $0.33 (N/M Forward P/E, -725.2% operating margin), whereas FEMY carries 52.6/100 (HOLD) at $1.28 (N/M Forward P/E, -763.9% operating margin).
Technical & Structure Timing Caution: SPRC is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 14.5); meanwhile FEMY is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 34.6). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on SPRC vs FEMY. Trailing 12-month operating profitability (SPRC -725.2% vs FEMY -763.9%) and valuation multiples (SPRC N/M vs FEMY N/M Forward P/E) are benchmarked directly in Pillar 4 below.
Competes within the Medical Instruments & Supplies value chain with $11.9M market capitalization and -763.9% operating margin.
OpEx & R&D ReinvestmentN/A
90D Engineering Disclosures0 Published
Investor FAQ SPRC vs FEMY Key Questions & Quantitative Answers
As of Nov 16, 2026, Femasys Inc. (FEMY) is the stronger overall head-to-head candidate over SciSparc Ltd. (SPRC) in the Tradestie Institutional Equity Comparison Engine, winning 5–2 core matrix metrics and 2–2 across our 6-pillar institutional scorecard (led by Growth & Scale, Balance Sheet & Cash Flow). SPRC carries a Unified Composite Score of 49.8/100 (HOLD) at $0.33 (N/M Forward P/E, -725.2% operating margin), whereas FEMY carries 52.6/100 (HOLD) at $1.28 (N/M Forward P/E, -763.9% operating margin). Technical & Structure Timing Caution: SPRC is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 14.5); meanwhile FEMY is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 34.6). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
FEMY leads the Growth & Scale pillar: SPRC posts -38.4% YoY revenue growth and +0.0% YoY earnings growth on $679,000 TTM revenue (N/A gross margin, -725.2% operating margin), compared with FEMY at -18.9% YoY revenue growth and +0.0% YoY earnings growth on $2.3M TTM revenue (60.9% gross margin, -763.9% operating margin). On trailing 12-month operating scale, SPRC generates $679,000 in USD-normalized revenue versus $2.3M for FEMY. In operating R&D and SG&A reinvestment, SPRC deploys N/A (0 90-day corporate R&D disclosures) versus N/A (0 disclosures) for FEMY.
SPRC screens cheaper on headline valuation multiples. SPRC trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and 1.3x EV/Revenue (unreported EBITDA margin), whereas FEMY trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and 4.9x EV/Revenue (unreported FCF margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against SPRC (-164.5% ROE) versus FEMY (-425.0% ROE) capital efficiency.
In options market volatility and institutional positioning, SPRC carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.01β · 159% Vol realized risk). By comparison, FEMY carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (4.01β · 72% Vol realized risk).
Cross-Compare 1-Click Peer Rivalries & Single-Stock Research
Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 16, 2026. For educational research only; not investment advice.